Hugo Ramos

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Neuroprotection in Early Diabetic Retinal Disease Using Eyedrop Delivery.

Neuroprotection in Early Diabetic Retinal Disease Using Eyedrop Delivery.

Journal: International journal of molecular sciences

Published: May 13, 2026

Eyedrop Administration of DPP-4 Inhibitors: A New Strategy for Treating Early Stages of Diabetic Retinal Disease.

Eyedrop Administration of DPP-4 Inhibitors: A New Strategy for Treating Early Stages of Diabetic Retinal Disease.

Journal: International journal of molecular sciences

Published: March 25, 2026

Neuroprotection in Diabetes Retinal Disease: An Unmet Medical Need.

Neuroprotection in Diabetes Retinal Disease: An Unmet Medical Need.

Journal: International journal of molecular sciences

Published: December 16, 2025

Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone.

Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone.

Journal: International journal of molecular sciences

Published: October 24, 2025

Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components.

Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components.

Journal: Eye (London, England)

Published: May 23, 2025

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data.

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 07, 2024

Sitagliptin eye drops prevent the impairment of retinal neurovascular unit in the new Trpv2+/- rat model.

Sitagliptin eye drops prevent the impairment of retinal neurovascular unit in the new Trpv2+/- rat model.

Journal: Journal of neuroinflammation

Published: July 15, 2024

Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications.

Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications.

Journal: International journal of molecular sciences

Published: April 06, 2023

Blocking Hemopexin With Specific Antibodies: A New Strategy for Treating Diabetic Retinopathy.

Blocking Hemopexin With Specific Antibodies: A New Strategy for Treating Diabetic Retinopathy.

Journal: Diabetes

Published: January 09, 2023

Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies.

Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies.

Journal: Nutrients

Published: December 31, 2022

Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy.

Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy.

Journal: International journal of molecular sciences

Published: October 27, 2022

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy.

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy.

Journal: Antioxidants (Basel, Switzerland)

Published: June 30, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026